Redi offers a tailored and complete support experience for patients and healthcare partners, simplifying and customizing the complete health journey with personalized care and support.

Nate Rehm

Jaimin Gandhi

Luke Buchanan

Redi

In 2021 Redi.Health was founded with a simple goal: Empower patients to take control of and contribute to their health journey. We believe that when it comes to healthcare, the patient is often forgotten and left to navigate the overwhelming world of healthcare on their own.  

To fix this problem we developed Redi.Health. Redi puts more simplified tools in the hands of patients than ever before and creates novel pathways of connectivity to the support and resources patients wouldn’t otherwise have access to.

It’s simple – we believe in patients and giving them the tools to take control of their health.

Rev1 Ventures

Mutual Capital Partners

Plug and Play

Refinery Ventures

Redi.Health

We are thrilled to announce the close of our Series B led by Blue Heron Capital with participation from North Coast Ventures, Refinery Ventures, Mutual Capital Partners, Rev1 Ventures, and M25. 

This represents a critical step forward in our journey to empower patients in their care. 

We are Redi for the next chapter 🚀

https://lnkd.in/gzinpCR9

I am looking for a React Native expert to join us here at Redi!

Redi is continuing to expand our team! More open roles are available today including:

Director of Product, Pharma
Lead Product Manager, Growth

Redi Health is an organization of active, passionate, and fun individuals that are diversely skilled and full of EQ. If being a part of a mission to create a health platform for all appeals to you, click the link below to apply. 

https://lnkd.in/e-4SaEez

Redi is looking for two Senior Engineers to join our incredibly talented team!

Current open roles are:
- Senior Software Engineer, Infrastructure
- Senior Software Engineer, Mobile 

Click the link to learn more and apply to be on the frontlines of changing the standard of healthcare. 

https://lnkd.in/eErQDy6F

Julianne (Julie) Morrow is in the spotlight today! 

Julie joined the Redi team in September and hit the ground running. She is incredibly detail oriented, has a gift for organization and standardizing processes and keeps the team on pace to hit our goals. She loves her dog, traveling, home improvement projects and Trader Joe's! 

Ultimately, Julie makes this team better and for that, Redi is extremely grateful!

Metric
Company Name	Redi
Symbol
MSH ID	HEALTH:REDI
Market	PRIVATE
Sector	8
Industry	Healthcare & Health Services
Country	US
Stage
Employee Count	25
Website	redi.health
LinkedIn	redi-health
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

HEALTH:REDI

Redi

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue